Leap Consulting Group has launched a practice aimed at guiding Clinical Laboratory Improvement Amendments-certified labs (CLIA) in adhering to the US Food and Drug Administration's (FDA) Final Rule over the classification of laboratory-developed tests (LDTs). The post Leap Consulting launches practice to assist labs with FDA's LDT ruling appeared first on Medical Device Network.
